COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

23,551 Articles (17,940 medRxiv, 5,611 bioRxiv)

Most recent first Previous |  Page 2015: Articles 20141-20150  | Next

Modeling the Impact of Nationwide BCG Vaccine Recommendations on COVID-19 Transmission, Severity, and Mortality
Shah, N. H., Suthar, A., Satia, M. H., Shah, Y., Shukla, N., Shukla, J., Shukla, D.
10.1101/2020.05.10.20097121 — Posted: 2020-05-14
Spread of COVID-19 in India: A Simple Algebraic Study
Roy, S.
10.1101/2020.05.10.20097691 — Posted: 2020-05-14
A dynamic model for Covid-19 in Brazil.
Lichtenthaler Filho, R., Lichtenthaler, D. G.
10.1101/2020.05.10.20097550 — Posted: 2020-05-14
Hidden periods, duration and final size of COVID-19 pandemic
Nesteruk, I.
10.1101/2020.05.10.20097147 — Posted: 2020-05-14
Early Safety Indicators of COVID-19 ConvalescentPlasma in 5,000 Patients
Joyner, M., Wright, R. S., Fairweather, D., Senefeld, J., Bruno, K., Klassen, S., Carter, R., Klompas, A., Wiggins, C., Shepherd, J. R., Rea, R., Whelan, E., Clayburn, A., Spiegel, M., Johnson, P., Lesser, E., Baker, S., Larson, K., Ripoll Sanz, J., Andersen, K., Hodge, D., Kunze, K., Buras, M., Vogt, M., Herasevich, V., Dennis, J., Regimbal, R., Bauer, P., Blair, J., van Buskirk, C., Winters, J., Stubbs, J., Paneth, N., Casadevall, A.
10.1101/2020.05.12.20099879 — Posted: 2020-05-14 Discussion: Onsite
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study
Regina, J., Papadimitriou-Olivgeris, M., Burger, R., Filippidis, P., Tschopp, J., Desgranges, F., Viala, B., Kampouri, E., Rochat, L., Haefliger, D., Belkoniene, M., Fidalgo, C., Kritikos, A., Jaton, K., Senn, L., Bart, P.-A., Pagani, J.-L., Manuel, O., Lhopitallier, L.
10.1101/2020.05.11.20097741 — Posted: 2020-05-14
Systemic corticosteroids show no benefit in severe and critical COVID-19 patients in Wuhan, China: A retrospective cohort study
Wu, J., Huang, J., Zhu, G., Liu, Y., Xiao, H., Zhou, Q., Si, X., Yi, H., Wang, C., Yang, D., Chen, S., Liu, X., Liu, Z., Wang, Q., Lv, Q., Huang, Y., Yu, Y., Guan, X., Li, Y., Nirantharakumar, K., Cheng, K., Peng, S., Xiao, H.
10.1101/2020.05.11.20097709 — Posted: 2020-05-14
Laboratory validation of an RNA/DNA hybrid tagmentation based mNGS workflow on SARS-CoV-2 and other respiratory RNA viruses detection
Wei, F., Yu, Y., Hu, Z., Wang, R., Guo, X., Jin, H., Guo, S., Ouyang, Y., Shi, Y., Jin, R., Chen, D.
10.1101/2020.05.12.20099754 — Posted: 2020-05-14
Deep Transfer Learning-based COVID-19 prediction using Chest X-rays
Kumar, S., Mishra, S., Singh, S. K.
10.1101/2020.05.12.20099937 — Posted: 2020-05-14
Machine learning model estimating number of COVID-19 infection cases over coming 24 days in every province of South Korea (XGBoost and MultiOutputRegressor)
Suzuki, Y., Suzuki, A.
10.1101/2020.05.10.20097527 — Posted: 2020-05-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).